Cardiorespiratory Response During Whole Body Vibration Training in Patients With Chronic Lung Disease
NCT ID: NCT01898143
Last Updated: 2016-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2013-06-30
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Vibration Training on Exercise Capacity in COPD-patients
NCT01380639
Vibration Training in Chronic Obstructive Pulmonary Disease (COPD)-Patients During a Three-week Rehabilitation
NCT01380652
Whole Body Vibration in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01649310
Whole Body Vibration in Chronic Obstructive Pulmonary Disease
NCT01850173
The Effects of Different Vibration Exercises on COPD Patients
NCT06413524
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Whole body vibration in COPD
Patients with COPD GOLD III or IV
Whole body vibration
Whole body vibration in ILD
PAtients with interstitial lung disease
Whole body vibration
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Whole body vibration
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Interstitial Lung disease (forced vital capacity (FVC) \< 70% pred., diffusion capacity of lung for carbon monoxide (DLCO) 30-70% pred.)
Exclusion Criteria
* Severe exacerbation of lung disease, with necessity of change in medication or persistent symptoms \> 3days
* activated arthrosis /arthropathy/ rheumatoid Arthritis/ acute discopathy
* acute thrombosis
* acute musculoskeletal inflammation
* Epilepsy
* Gallstones
20 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Schön Klinik Berchtesgadener Land
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Klaus Kenn
Head Physican (department of pneumology)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Schön Klinik Berchtesgadener Land
Schönau am Königssee, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SpiroErgoGalileo-2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.